(CBC) Central Bancompany, Common - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US1524131000
Stock:
Total Rating 42
Risk 62
Buy Signal -0.33
| Risk 5d forecast | |
|---|---|
| Volatility | 41.4% |
| Relative Tail Risk | -26.1% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.55 |
| Alpha | 93.53 |
| Character TTM | |
|---|---|
| Beta | 0.137 |
| Beta Downside | -0.284 |
| Drawdowns 3y | |
|---|---|
| Max DD | 20.26% |
| CAGR/Max DD | 4.77 |
EPS (Earnings per Share)
Revenue
Description: CBC Central Bancompany, Common
Central Bancompany, Inc. operates as the bank holding company for The Central Trust Bank that provides consumer, commercial, and wealth management products and services. It provides savings and checking, certificate of deposit, individual retirement, money market, time deposit, health savings, and interest-bearing and noninterest-bearing checking accounts. The company also offers commercial and industrial loans, one-to four-family residential loans, home equity and mortgage loans, multi-family loans, commercial real estate loans, construction and development loans, consumer loans, and powersport, auto, agricultural, business expansion, equipment, lease and municipal, real estate, working capital, personal, student, and SBA loans, as well as home equity, lines and letters of credit, commercial lending, and various loans. In addition, it provides wealth and cash management services, merchant services, collection and receivables, payment and disbursements, and debit and credit cards. Further, the company offers mobile, online, and e-banking services. The company operates through a network of banking offices in in Missouri, Kansas, Oklahoma, and Colorado. Central Bancompany, Inc. was founded in 1902 and is headquartered in Jefferson City, Missouri.
Piotroski VR‑10 (Strict, 0-10) 1.5
| Net Income: 305.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 0.10 > 1.0 |
| NWC/Revenue: error (cannot be calculated; needs Current Assets/Liabilities and Revenue current+prev) |
| CFO/TA 0.02 > 3% & CFO 363.3m > Net Income 305.8m |
| Net Debt/EBITDA: error (cannot be calculated) |
| Current Ratio: error (cannot be calculated; needs correct Total Current Assets and Liabilities) |
| Outstanding Shares: last fiscal year (4.41m) vs prev -0.26% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 4.72% > 50% (prev 4.42%; Δ 0.30% > 0%) |
| Interest Coverage Ratio: 2.81 > 6 (EBITDA TTM 630.6m / Interest Expense TTM 217.7m) |
Altman Z''
| A: error (Total Current Assets none - Total Current Liabilities none) / Total Assets 19.02b |
| B: 0.18 (Retained Earnings 3.33b / Total Assets 19.02b) |
| C: 0.03 (EBIT TTM 611.4m / Avg Total Assets 19.02b) |
| D: 0.20 (Book Value of Equity 3.33b / Total Liabilities 16.28b) |
Beneish M
| DSRI: none (Receivables none/none, Revenue 897.7m/840.1m) |
| GMI: 1.0 (GM 100.0% / 100.0%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 1.07 (Revenue 897.7m / 840.1m) |
| TATA: -0.00 (NI 305.8m - CFO 363.3m) / TA 19.02b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of CBC shares?
As of March 02, 2026, the stock is trading at USD 24.15 with a total of 390,917 shares traded.
Over the past week, the price has changed by -0.66%, over one month by -2.55%, over three months by +3.97% and over the past year by +82.89%.
Over the past week, the price has changed by -0.66%, over one month by -2.55%, over three months by +3.97% and over the past year by +82.89%.
Is CBC a buy, sell or hold?
Central Bancompany, Common has no consensus analysts rating.
What are the forecasts/targets for the CBC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 29.1 | 20.5% |
| Analysts Target Price | - | - |
CBC Fundamental Data Overview February 28, 2026
P/E Trailing = 17.6475
P/S = 5.8439
P/B = 1.3886
Revenue TTM = 897.7m USD
EBIT TTM = 611.4m USD
EBITDA TTM = 630.6m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 4.68b USD (5.91b + (null Debt) - CCE 1.24b)
Interest Coverage Ratio = 2.81 (Ebit TTM 611.4m / Interest Expense TTM 217.7m)
EV/FCF = 13.84x (Enterprise Value 4.68b / FCF TTM 338.1m)
FCF Yield = 7.23% (FCF TTM 338.1m / Enterprise Value 4.68b)
FCF Margin = 37.67% (FCF TTM 338.1m / Revenue TTM 897.7m)
Net Margin = 34.07% (Net Income TTM 305.8m / Revenue TTM 897.7m)
Gross Margin = unknown ((Revenue TTM 897.7m - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = 0.25 (Enterprise Value 4.68b / Total Assets 19.02b)
Interest Expense / Debt = unknown (Interest Expense 217.7m / Debt none)
Taxrate = 22.33% (87.9m / 393.7m)
NOPAT = 474.9m (EBIT 611.4m * (1 - 22.33%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 630.6m)
Debt / FCF = unknown (Net Debt none / FCF TTM 338.1m)
Total Stockholder Equity = 3.11b (last fiscal year from totalStockholderEquity)
RoA = 1.61% (Net Income 305.8m / Total Assets 19.02b)
RoE = 9.83% (Net Income TTM 305.8m / Total Stockholder Equity 3.11b)
RoCE = unknown (EBIT 611.4m / Capital Employed )
RoIC = unknown (NOPAT 474.9m, Invested Capital 0.0, EBIT 611.4m)
WACC = 6.42% (E(5.91b)/V(5.91b) * Re(6.42%) + (debt-free company))
Discount Rate = 6.42% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
[DCF] Terminal Value 84.78% ; FCFF base≈330.6m ; Y1≈348.5m ; Y5≈410.1m
[DCF] Fair Price = 42.97 (EV 10.36b - Net Debt 0.0 = Equity 10.36b / Shares 241.1m; r=6.42% [WACC]; 5y FCF grow 5.93% → 2.90% )
EPS Correlation: 82.14 | EPS CAGR: 12.77% | SUE: N/A | # QB: 0
Revenue Correlation: N/A | Revenue CAGR: 0.0% | SUE: N/A | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.46 | Chg7d=+0.014 | Chg30d=+0.014 | Revisions Net=+3 | Analysts=5
EPS current Year (2026-12-31): EPS=1.86 | Chg7d=+0.066 | Chg30d=+0.066 | Revisions Net=+4 | Growth EPS=+3.0% | Growth Revenue=+7.0%
EPS next Year (2027-12-31): EPS=1.95 | Chg7d=+0.020 | Chg30d=+0.012 | Revisions Net=+2 | Growth EPS=+4.3% | Growth Revenue=+6.0%
[Analyst] Revisions Ratio: +1.00 (3 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.3% (Discount Rate 7.9% - Earnings Yield 5.7%)
[Growth] Growth Spread = -2.3% (Analyst 0.0% - Implied 2.3%)
P/S = 5.8439
P/B = 1.3886
Revenue TTM = 897.7m USD
EBIT TTM = 611.4m USD
EBITDA TTM = 630.6m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 4.68b USD (5.91b + (null Debt) - CCE 1.24b)
Interest Coverage Ratio = 2.81 (Ebit TTM 611.4m / Interest Expense TTM 217.7m)
EV/FCF = 13.84x (Enterprise Value 4.68b / FCF TTM 338.1m)
FCF Yield = 7.23% (FCF TTM 338.1m / Enterprise Value 4.68b)
FCF Margin = 37.67% (FCF TTM 338.1m / Revenue TTM 897.7m)
Net Margin = 34.07% (Net Income TTM 305.8m / Revenue TTM 897.7m)
Gross Margin = unknown ((Revenue TTM 897.7m - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = 0.25 (Enterprise Value 4.68b / Total Assets 19.02b)
Interest Expense / Debt = unknown (Interest Expense 217.7m / Debt none)
Taxrate = 22.33% (87.9m / 393.7m)
NOPAT = 474.9m (EBIT 611.4m * (1 - 22.33%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 630.6m)
Debt / FCF = unknown (Net Debt none / FCF TTM 338.1m)
Total Stockholder Equity = 3.11b (last fiscal year from totalStockholderEquity)
RoA = 1.61% (Net Income 305.8m / Total Assets 19.02b)
RoE = 9.83% (Net Income TTM 305.8m / Total Stockholder Equity 3.11b)
RoCE = unknown (EBIT 611.4m / Capital Employed )
RoIC = unknown (NOPAT 474.9m, Invested Capital 0.0, EBIT 611.4m)
WACC = 6.42% (E(5.91b)/V(5.91b) * Re(6.42%) + (debt-free company))
Discount Rate = 6.42% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
[DCF] Terminal Value 84.78% ; FCFF base≈330.6m ; Y1≈348.5m ; Y5≈410.1m
[DCF] Fair Price = 42.97 (EV 10.36b - Net Debt 0.0 = Equity 10.36b / Shares 241.1m; r=6.42% [WACC]; 5y FCF grow 5.93% → 2.90% )
EPS Correlation: 82.14 | EPS CAGR: 12.77% | SUE: N/A | # QB: 0
Revenue Correlation: N/A | Revenue CAGR: 0.0% | SUE: N/A | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.46 | Chg7d=+0.014 | Chg30d=+0.014 | Revisions Net=+3 | Analysts=5
EPS current Year (2026-12-31): EPS=1.86 | Chg7d=+0.066 | Chg30d=+0.066 | Revisions Net=+4 | Growth EPS=+3.0% | Growth Revenue=+7.0%
EPS next Year (2027-12-31): EPS=1.95 | Chg7d=+0.020 | Chg30d=+0.012 | Revisions Net=+2 | Growth EPS=+4.3% | Growth Revenue=+6.0%
[Analyst] Revisions Ratio: +1.00 (3 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.3% (Discount Rate 7.9% - Earnings Yield 5.7%)
[Growth] Growth Spread = -2.3% (Analyst 0.0% - Implied 2.3%)